Do the Drugs that Keep HIV Patients Alive Damage Their Brains?

URMC researchers are studying whether drugs used to keep HIV patients alive could be damaging their brains. Early results from their clinical study suggest that these drugs do not pose a threat to the brain - at least in the short-term. 

UR CTSI Clinical Research Center: Testing Tomorrow's Therapies Today

The UR CTSI's Clinical Research Center is a dedicated space with a highly trained staff where researchers can conduct clinical trials on a myriad of diseases and conditions. Two clinical trial volunteers discuss their hopes and motivations for joining research studies through the Clinical Research Center. 

UR CTSI Wins ResearchMatch.org Social Media Contest

ResearchMatch.org (RM), an online clinical study recruitment tool, recently organized a social media campaign and competition to recognize its users and spread the word about their service. UR CTSI is one of 133 institutions in the RM network and won first place in the social media campaign competition. This wins gives UR CTSI more resources to get researchers and study volunteers registered with RM. 

New Requirements for Clinical Trials: What You Need to Know

New expanded legal policies from the U.S. Department of Health and Human Services and National Institutes of Health regarding registering and reporting results of clinical trials as well as funding and training will apply to many clinical trials that were not previously under any formal obligations. This article outlines what you need to know and a town hall meeting will be held October 27 to clarify details of the policies and answer any questions. 

Testing New Ways to Enroll At-Risk Populations in Clinical Research

A new award from the HIV Vaccine Trials Network will allow investigators to evaluate whether the computer tablet-based health survey “e-screening” tool, Promote Health, will help recruit and retain high-risk individuals into an HIV prevention clinical trial.